8,495
Views
26
CrossRef citations to date
0
Altmetric
Short Report

Effectiveness of booster BCG vaccination in preventing Covid-19 infection

, , , , &
Pages 3913-3915 | Received 16 Apr 2021, Accepted 11 Jul 2021, Published online: 17 Aug 2021

References

  • Berg MK, Yu Q, Salvador CE, Melani I, Kitayama S. Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19. Sci Adv. 2020 Aug 5;6(32):eabc1463. doi:10.1126/sciadv.abc1463. PMID:32923613; PMCID:PMC7457335.
  • Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv. 2020;2020.03.24.20042937.
  • Wardhana DEA, Sultana A, Mandang VV, Jim E. The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly. Acta Med Indones. 2011;43:185–90.
  • Lopez-Martin I, Andres Esteban E, Garcia-Martinez FJ. Relationship between MMR vaccination and severity of Covid-19 infection. Survey among primary care physicians. Med Clin (Engl Ed). 2021;156:140–41.
  • Marakasova E, Baranova A. MMR vaccine and COVID-19: measles protein homology may contribute to cross-reactivity or to complement activation protection. mBio. 2021;12. doi:10.1128/mBio.03447-20.
  • Higgins J, Soares-Weiser K, Reingold A. Systematic review of the non-specific effects of BCG, DTP and measles containing vaccines. WHO Rt, ed. Report to WHO Report to WHO 2014.
  • Leentjens J, Kox M, Stokman R, Gerretsen J, Diavatopoulos DA, Van Crevel R, Rimmelzwaan GF, Pickkers P, Netea MG. BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study. J Infect Dis. 2015;212:1930–38. doi:10.1093/infdis/jiv332.
  • Higgins JP, Soares-Weiser K, Lopez-Lopez JA, Kakourou A, Chaplin K, Christensen H, Martin NK, Sterne JAC, Reingold AL. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ. 2016;355:i5170. doi:10.1136/bmj.i5170.
  • Netea MG, Van Crevel R. BCG-induced protection: effects on innate immune memory. Semin Immunol. 2014;26:512–17. doi:10.1016/j.smim.2014.09.006.
  • Gupta N, Garg S, Vedi S, Kunimoto DY, Kumar R, Agrawal B. Future path toward TB vaccine development: boosting BCG or re-educating by a new subunit vaccine. Front Immunol. 2018;9:2371. doi:10.3389/fimmu.2018.02371.
  • Whittaker E, Nicol MP, Zar HJ, Tena-Coki NG, Kampmann B. Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries. Sci Rep. 2018;8:15309. doi:10.1038/s41598-018-33499-4.
  • Kelleni MT. BCG vaccination potential for COVID-19: an analytical approach. Hum Vaccin Immunother. 2021;1–3. doi:10.1080/21645515.2021.1885281.
  • Gonzalez-Perez M, Sanchez-Tarjuelo R, Shor B, Nistal-Villan E, Ochando J. The BCG vaccine for COVID-19: first verdict and future directions. Front Immunol. 2021;12:632478. doi:10.3389/fimmu.2021.632478.
  • Koneru G, Batiha GE, Algammal AM, Mabrok M, Magdy S, Sayed S, AbuElmagd ME, Elnemr R, Saad MM, Abd Ellah NH, et al. BCG vaccine-induced trained immunity and COVID-19: protective or bystander? Infect Drug Resist. 2021;14:1169–84. doi:10.2147/IDR.S300162.
  • Escobar LE, Molina-Cruz A, Barillas-Mury C. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc Natl Acad Sci. 2020;117:17720–17726.
  • Netea MG, van der Meer JW, Van Crevel R. BCG vaccination in health care providers and the protection against COVID-19. J Clin Invest. 2021;131:e145545. doi:10.1172/JCI145545
  • Rivas MN, Ebinger JE, Wu M, Sun N, Braun J, Sobhani K, Van Eyk JE, Cheng S, Arditi M. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers. J Clin Invest. 2021;131:e145157. doi:10.1172/JCI145157.
  • Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8:e1001012. doi:10.1371/journal.pmed.1001012.
  • BCG vaccines: WHO position.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.